Related content

Advances towards the design and development of personalized non-small-cell lung cancer drug therapy

By Vari Sabrina   Pilotto Sara   Maugeri-Saccà Marcello   Ciuffreda Ludovica   Cesta Incani Ursula   Falcone Italia   Del Curatolo Anais   Ceribelli Anna   Gelibter Alain   De Maria Ruggero   Tortora Giampaolo   Cognetti Francesco   Bria Emilio   Milella Michele  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1381-1397

Informa Healthcare

Access to resources Recommend Favorite

Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives

By Lamonaca Palma   Prinzi Giulia   Kisialiou Aliaksei   Cardaci Vittorio   Fini Massimo   Russo Patrizia  

Marine Drugs, Vol. 15, Iss. 3, 2017-03 ,pp. : 81-81

MDPI

Access to resources Recommend Favorite

Advancement Towards Tin-based Anticancer Chemotherapeutics: Structural Modification and Computer Modeling Approach to Drug-Enzyme Interactions

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 24, 2012-12 ,pp. : 2810-2826

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine

By Vizirianakis I.S.  

European Journal of Pharmaceutical Sciences, Vol. 15, Iss. 3, 2002-04 ,pp. : 243-250

Elsevier

Access to resources Recommend Favorite

Pharmacogenomics in Drug-Metabolizing Enzymes Catalyzing Anticancer Drugs for Personalized Cancer Chemotherapy

By  

Current Drug Metabolism, Vol. 8, Iss. 6, 2007-08 ,pp. : 554-562

Bentham Science Publishers

Access to resources Recommend Favorite